Holen Sie sich die Stockscreener-App
563.00
3.72%
-21.75
Handel nachbörslich:
558.25
-4.75
-0.84%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt IDXX?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$584.75
Offen:
$579.67
24-Stunden-Volumen:
483.66K
Relative Volume:
0.93
Marktkapitalisierung:
$44.72B
Einnahmen:
$4.30B
Nettoeinkommen (Verlust:
$1.06B
KGV:
43.04
EPS:
13.0798
Netto-Cashflow:
$1.04B
1W Leistung:
-1.15%
1M Leistung:
-5.99%
6M Leistung:
-8.63%
1J Leistung:
+47.45%
1-Tages-Spanne:
$559.39
$582.24
1-Wochen-Bereich:
$559.39
$605.82
52-Wochen-Spanne:
$375.06
$769.98
Idexx Laboratories Inc Stock (IDXX) Company Profile
Firmenname
Idexx Laboratories Inc
Sektor
Branche
Telefon
(207) 556-0300
Adresse
ONE IDEXX DRIVE, WESTBROOK, ME
Compare IDXX vs TMO, DHR, A, WAT
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IDXX
Idexx Laboratories Inc
|
563.00 | 44.72B | 4.30B | 1.06B | 1.04B | 13.08 |
TMO
Thermo Fisher Scientific Inc
|
496.11 | 184.37B | 44.56B | 6.72B | 6.29B | 17.74 |
DHR
Danaher Corp
|
189.61 | 134.19B | 24.57B | 3.60B | 5.26B | 5.051 |
A
Agilent Technologies Inc
|
115.06 | 32.52B | 7.07B | 1.29B | 993.00M | 4.5355 |
WAT
Waters Corp
|
320.00 | 31.39B | 3.17B | 642.63M | 516.49M | 10.77 |
Idexx Laboratories Inc Stock (IDXX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-09 | Eingeleitet | Barclays | Overweight |
| 2025-10-31 | Hochstufung | Stifel | Hold → Buy |
| 2025-10-01 | Eingeleitet | UBS | Neutral |
| 2025-08-05 | Bestätigt | BTIG Research | Buy |
| 2025-07-01 | Eingeleitet | Jefferies | Buy |
| 2024-12-02 | Eingeleitet | Leerink Partners | Outperform |
| 2024-07-25 | Eingeleitet | BTIG Research | Buy |
| 2024-01-30 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2023-12-07 | Eingeleitet | Exane BNP Paribas | Outperform |
| 2023-12-04 | Hochstufung | Cleveland Research | Neutral → Buy |
| 2023-08-02 | Herabstufung | Atlantic Equities | Overweight → Neutral |
| 2022-07-25 | Herabstufung | Stifel | Buy → Hold |
| 2022-07-21 | Hochstufung | Goldman | Neutral → Buy |
| 2022-07-12 | Eingeleitet | Piper Sandler | Overweight |
| 2022-05-05 | Herabstufung | BofA Securities | Buy → Neutral |
| 2022-02-08 | Eingeleitet | Atlantic Equities | Overweight |
| 2021-11-18 | Eingeleitet | Morgan Stanley | Overweight |
| 2021-08-05 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-07-12 | Herabstufung | Guggenheim | Buy → Neutral |
| 2021-02-17 | Eingeleitet | Barclays | Overweight |
| 2019-09-09 | Eingeleitet | Goldman | Neutral |
| 2019-05-23 | Eingeleitet | Guggenheim | Buy |
| 2018-11-02 | Bestätigt | BofA/Merrill | Buy |
| 2018-05-07 | Bestätigt | Stifel | Buy |
| 2018-01-16 | Eingeleitet | Piper Jaffray | Overweight |
| 2017-08-23 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2017-07-28 | Hochstufung | CL King | Neutral → Buy |
| 2017-02-03 | Herabstufung | Feltl & Co. | Hold → Sell |
| 2016-09-29 | Fortgesetzt | BofA/Merrill | Neutral |
| 2016-08-16 | Bestätigt | Stifel | Buy |
| 2016-08-03 | Hochstufung | Northcoast | Sell → Neutral |
| 2016-07-20 | Bestätigt | Canaccord Genuity | Buy |
| 2016-04-19 | Bestätigt | Canaccord Genuity | Buy |
| 2016-04-01 | Eingeleitet | CL King | Neutral |
| 2016-03-21 | Bestätigt | Stifel | Buy |
| 2016-02-04 | Eingeleitet | Credit Suisse | Outperform |
| 2015-10-29 | Bestätigt | Stifel | Buy |
| 2015-08-28 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2015-08-13 | Bestätigt | Stifel | Buy |
| 2015-07-23 | Bestätigt | Canaccord Genuity | Buy |
Alle ansehen
Idexx Laboratories Inc Aktie (IDXX) Neueste Nachrichten
IDEXX (IDXX) launches canine cancer detection panel in UK - MSN
IDEXX (IDXX) Launches Canine Cancer Detection Panel in UK - Insider Monkey
Aug EndMonth: Is IDEXX Laboratories Inc stock trending bullish2026 Chart Watch & Real-Time Buy Signal Alerts - baoquankhu1.vn
IDEXX Laboratories Inc (IDXX) Stock Down 3.7% -- Now Undervalued? GF Score: 99/100 - GuruFocus
IDEXX Laboratories slides as investors weigh analyst target cuts and executive reshuffle ahead of 2026 priorities - Quiver Quantitative
IDEXX Laboratories Inc. stock underperforms Friday when compared to competitors - MarketWatch
IDEXX Laboratories Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Earnings Update: What are analysts price targets for IDEXX Laboratories IncQuarterly Profit Review & Smart Money Movement Alerts - baoquankhu1.vn
Insider Sell: Can IDEXX Laboratories Inc sustain earnings growth2026 Institutional & Capital Efficient Trading Techniques - baoquankhu1.vn
Franklin Street Advisors Increases Stake in IDEXX Laboratories - National Today
IDEXX Laboratories, Inc. (IDXX) Stock Forecasts - Yahoo Finance
IDEXX Laboratories Inc. stock outperforms competitors on strong trading day - MarketWatch
IDEXX Laboratories to Release 2026 First Quarter Financial Results - Business Wire
IDEXX Laboratories, Inc. (IDXX) stock price, news, quote and history - Yahoo Finance UK
BofA Securities Maintains IDEXX Laboratories Inc(IDXX.US) With Hold Rating, Maintains Target Price $790 - 富途牛牛
Will UK Rollout of Early Canine Cancer Test Change IDEXX Laboratories' (IDXX) Preventive Care Narrative? - Yahoo Finance
Stock Analysis: Is IDEXX Laboratories Inc showing insider buyingEarnings Overview Report & Expert Curated Trade Setup Alerts - baoquankhu1.vn
IDEXX LABORATORIES INC (IDXX.VI) Q1 FY2025 earnings call transcript - Yahoo Finance
IDEXX Laboratories, Inc. (IDXX) Stock forecasts - Yahoo Finance UK
Here’s Why Analysts Have IDEXX Stock Priced at $742 - TIKR.com
Ideas Watch: Will IDEXX Laboratories Inc announce a stock split2026 Volatility Report & Growth Focused Stock Reports - baoquankhu1.vn
William Blair Maintains IDEXX Laboratories Inc(IDXX.US) With Buy Rating - moomoo.com
IDEXX Laboratories, Inc. $IDXX Shares Sold by Rathbones Group PLC - MarketBeat
IDEXX’s UK Canine Cancer Test Rollout Might Change The Case For Investing In IDEXX Laboratories (IDXX) - Sahm
Why Idexx Laboratories (IDXX) is a Top Growth Stock for the Long-Term - Yahoo Finance
Rally Mode: Can IDEXX Laboratories Inc deliver alphaDip Buying & AI Enhanced Market Trend Forecasts - baoquankhu1.vn
Idexx Laboratories (IDXX) Launches Cancer Detection Panel in UK - GuruFocus
Three Seasons Wealth LLC Has $1.55 Million Stake in IDEXX Laboratories, Inc. $IDXX - MarketBeat
Nisa Investment Advisors LLC Has $29.41 Million Holdings in IDEXX Laboratories, Inc. $IDXX - MarketBeat
IDEXX Announces UK Availability of Cancer Dx Panel for Early Detection of Canine Lymphoma - Business Wire
Can IDEXX Laboratories Inc sustain earnings growthMarket Sentiment Review & Capital Efficient Trading Techniques - baoquankhu1.vn
IDEXX Laboratories (NASDAQ:IDXX) Price Target Lowered to $675.00 at Stifel Nicolaus - MarketBeat
Stifel Maintains IDEXX Laboratories Inc(IDXX.US) With Buy Rating, Cuts Target Price to $675 - 富途牛牛
Spire Wealth Management Boosts IDEXX Laboratories Stock Position - National Today
Spire Wealth Management Raises Stock Position in IDEXX Laboratories, Inc. $IDXX - marketbeat.com
IDEXX LABORATORIES INC (NASDAQ:IDXX) Passes the Caviar Cruise Quality Stock Screen - ChartMill
Companion Animal Health Market Forecast 2026-2033 Featuring Strategic Analysis of Agrolabo, Boehringer Ingelheim, Ceva, Elanco, IDEXX Labs and More - Yahoo Finance
IDEXX Laboratories, Inc. $IDXX Shares Acquired by Beacon Investment Advisory Services Inc. - MarketBeat
DAVENPORT & Co LLC Reduces IDEXX Laboratories Stake - National Today
DAVENPORT & Co LLC Sells 1,857 Shares of IDEXX Laboratories, Inc. $IDXX - MarketBeat
IDXX (IDEXX Laboratories) Net Issuance of Preferred Stock : $0 Mil (TTM As of Dec. 2025) - GuruFocus
[ARS] IDEXX LABORATORIES INC /DE SEC Filing - Stock Titan
IDEXX (NASDAQ: IDXX) proxy details 2025 growth, CEO change and key governance votes - Stock Titan
Vanguard disaggregates holdings; IDEXX (NASDAQ: IDXX) shows zero - Stock Titan
IDEXX Laboratories, Inc. $IDXX Shares Acquired by Global X Japan Co. Ltd. - MarketBeat
Riverbridge Partners LLC Sells 5,734 Shares of IDEXX Laboratories, Inc. $IDXX - MarketBeat
Tikehau Investment Management's IDEXX Laboratories Inc(IDXX) Holding History - GuruFocus
IDEXX Laboratories Announces Executive Departure and $984,000 Separation Agreement with Nimrata Hunt, PhD - Minichart
IDEXX Laboratories (IDXX) Announces Executive Transition with De - GuruFocus
Idexx Laboratories Announces Executive Departure Amid Strategic Realignment - TipRanks
Idexx Laboratories announces executive departure and separation agreement - investing.com
Finanzdaten der Idexx Laboratories Inc-Aktie (IDXX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.29%
0.74%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):